New Adoptive T Cell Therapy Has EBV-Positive Lymphomas on the Run - a podcast by American Society of Clinical Oncology (ASCO)

from 2013-12-16T17:50:47

:: ::

Reflections on a new report describing the successful therapy of lymphomas using adoptively transferred T cells targeting EBV latent membrane proteins.

Further episodes of Journal of Clinical Oncology (JCO) Podcast

Further podcasts by American Society of Clinical Oncology (ASCO)

Website of American Society of Clinical Oncology (ASCO)